Skip to main content

B. Riley Securities Keeps Their Buy Rating on Vanda (VNDA)

Tipranks - Tipranks - Wed Feb 18, 8:05AM CST

B. Riley Securities analyst Madison Elsaadi reiterated a Buy rating on Vanda today and set a price target of $14.00.

President's Day Sale - 70% Off

According to TipRanks, Elsaadi is a 5-star analyst with an average return of 51.5% and a 53.33% success rate. Elsaadi covers the Healthcare sector, focusing on stocks such as Arrowhead Pharmaceuticals, Vanda, and Capricor Therapeutics.

In addition to B. Riley Securities, Vanda also received a Buy from H.C. Wainwright’s Ram Selvaraju in a report issued today. However, on February 13, TipRanks – xAI reiterated a Hold rating on Vanda (NASDAQ: VNDA).

See Insiders’ Hot Stocks on TipRanks >>

Based on Vanda’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $57.22 million and a GAAP net loss of $141.19 million. In comparison, last year the company earned a revenue of $53.19 million and had a GAAP net loss of $4.91 million

Read More on VNDA:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).